Targeting mutant p53 for cancer therapy: direct and indirect strategies

J Hu, J Cao, W Topatana, S Juengpanich, S Li… - Journal of hematology & …, 2021 - Springer
TP53 is a critical tumor-suppressor gene that is mutated in more than half of all human
cancers. Mutations in TP53 not only impair its antitumor activity, but also confer mutant p53 …

[HTML][HTML] Autophagy in health and disease: A comprehensive review

S Saha, DP Panigrahi, S Patil, SK Bhutia - Biomedicine & pharmacotherapy, 2018 - Elsevier
Autophagy, a conserved catabolic process, plays an immensely significant role in a variety
of diseases. However, whether it imparts a protective function in diseases remains …

Roles of autophagy in oxidative stress

HR Yun, YH Jo, J Kim, Y Shin, SS Kim… - International journal of …, 2020 - mdpi.com
Autophagy is a catabolic process for unnecessary or dysfunctional cytoplasmic contents by
lysosomal degradation pathways. Autophagy is implicated in various biological processes …

Neuronal death mechanisms and therapeutic strategy in ischemic stroke

R Mao, N Zong, Y Hu, Y Chen, Y Xu - Neuroscience bulletin, 2022 - Springer
Ischemic stroke caused by intracranial vascular occlusion has become increasingly
prevalent with considerable mortality and disability, which gravely burdens the global …

The complexity of p53-mediated metabolic regulation in tumor suppression

Y Liu, W Gu - Seminars in cancer biology, 2022 - Elsevier
Although the classic activities of p53 including induction of cell-cycle arrest, senescence,
and apoptosis are well accepted as critical barriers to cancer development, accumulating …

Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted …

M Liao, R Qin, W Huang, HP Zhu, F Peng… - Journal of Hematology & …, 2022 - Springer
Triple-negative breast cancer (TNBC) is a subtype of human breast cancer with one of the
worst prognoses, with no targeted therapeutic strategies currently available. Regulated cell …

Mutant p53 in cancer therapy—the barrier or the path

X Zhou, Q Hao, H Lu - Journal of molecular cell biology, 2019 - academic.oup.com
Since wild-type p53 is central for maintaining genomic stability and preventing oncogenesis,
its coding gene TP53 is highly mutated in~ 50% of human cancers, and its activity is almost …

The dual role of autophagy in cancer development and a therapeutic strategy for cancer by targeting autophagy

CW Yun, J Jeon, G Go, JH Lee, SH Lee - International journal of …, 2020 - mdpi.com
Autophagy is a delicate intracellular degradation process that occurs due to diverse stressful
conditions, including the accumulation of damaged proteins and organelles as well as …

Targeting autophagy using metallic nanoparticles: A promising strategy for cancer treatment

M Cordani, Á Somoza - Cellular and molecular life sciences, 2019 - Springer
Despite the extensive genetic and phenotypic variations present in the different tumors, they
frequently share common metabolic alterations, such as autophagy. Autophagy is a self …

p53-mediated molecular control of autophagy in tumor cells

M Mrakovcic, LF Fröhlich - Biomolecules, 2018 - mdpi.com
Autophagy is an indispensable mechanism of the eukaryotic cell, facilitating the removal and
renewal of cellular components and thereby balancing the cell's energy consumption and …